|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Hydroxysteroid Dehydrogenase Type 1 with RNA Interference Substantially Attenuates 3T3-L1 Adipogenesis
1 Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
2 Department of Medicine; Kidney Disease Center, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
3 Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
4 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States
* To whom correspondence should be addressed. E-mail: liang.pgeditor{at}mcw.edu.
11
-hydroxysteroid dehydrogenase type 1 (11
-HSD1), which regulates the local level of glucocorticoids, has been shown to be involved in the development of obesity. A definitive functional role for 11
-HSD1 in adipogenesis, however, remains to be established. We developed 3T3-L1 cell lines stably transfected with a small hairpin RNA (shRNA) targeting 11
-HSD1. A shRNA containing two nucleotide substitutions was used as a control. Silencing of 11
-HSD1 substantially attenuated the accumulation of lipid droplets and the expression of adipogenesis marker genes, which was induced by a mixture containing either corticosterone or dexamethasone. Silencing of 11
-HSD1 increased the concentration of 11-dehydrocorticosterone in the culture supernatant, but did not significantly affect the levels of corticosterone or dexamethasone. Translocation of glucocorticoid receptors to the nucleus in response to glucocorticoids was significantly attenuated by silencing 11
-HSD1. The number of cells entering the S phase of the cell cycle following the induction of adipogenesis was significantly reduced by silencing 11
-HSD1. 11
-HSD1 shRNA delivered by lentiviral vectors after the induction of differentiation, however, did not affect the progression of adipogenesis. These results indicate that 11
-HSD1 plays a significant functional role in the initiation of 3T3-L1 adipogenesis, and provide new mechanistic insights into the role of 11
-HSD1 in the development of obesity and related diseases.
This article has been cited by other articles:
![]() |
Z. Tian, Y. Liu, K. Usa, D. Mladinov, Y. Fang, X. Ding, A. S. Greene, A. W. Cowley Jr, and M. Liang Novel Role of Fumarate Metabolism in Dahl-Salt Sensitive Hypertension Hypertension, August 1, 2009; 54(2): 255 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Su, K. Shankar, and R. C. M. Simmen Early Soy Exposure via Maternal Diet Regulates Rat Mammary Epithelial Differentiation by Paracrine Signaling from Stromal Adipocytes J. Nutr., May 1, 2009; 139(5): 945 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, D. Mladinov, J. L. Pietrusz, K. Usa, and M. Liang Glucocorticoid response elements and 11{beta}-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression Cardiovasc Res, January 1, 2009; 81(1): 140 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, R. J. Singh, K. Usa, B. C. Netzel, and M. Liang Renal medullary 11{beta}-hydroxysteroid dehydrogenase type 1 in Dahl salt-sensitive hypertension Physiol Genomics, December 12, 2008; 36(1): 52 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Balachandran, H. Guan, M. Sellan, S. van Uum, and K. Yang Insulin and Dexamethasone Dynamically Regulate Adipocyte 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Endocrinology, August 1, 2008; 149(8): 4069 - 4079. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Tian, A. S. Greene, K. Usa, I. R. Matus, J. Bauwens, J. L. Pietrusz, A. W. Cowley Jr, and M. Liang Renal Regional Proteomes in Young Dahl Salt-Sensitive Rats Hypertension, April 1, 2008; 51(4): 899 - 904. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |